Search results
Is AbbVie (ABBV) a High Growth Potential Stock?
Insider Monkey via Yahoo Finance· 2 years agoBaron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2022 investor letter. A copy of the same can be...
Here’s Why Baron Health Care Fund Trimmed AbbVie (ABBV)
Insider Monkey via Yahoo Finance· 11 months agoBaron Funds, an investment management company, released its “Baron Health Care Fund” first quarter...
Warren Buffett is Selling These 6 Stocks in 2022
Insider Monkey via Yahoo Finance· 2 years agoIn this article, we discuss 6 stocks that Warren Buffett is selling in 2022. If you want to see more stocks that the billionaire sold, click Warren...
AbbVie's (ABBV) Rinvoq Meets Key Goal in Phase II Vitiligo Study
Zacks via Yahoo Finance· 6 months agoAbbVie ABBV announced positive results from its mid-stage study evaluating Rinvoq (upadacitinib) in...
AbbVie (ABBV) Provides Clinical Updates on Inflammatory Drugs
Zacks via Yahoo Finance· 1 year agoAbbVie ABBV announced multiple clinical updates pertaining to clinical studies evaluating its...
AbbVie (ABBV) to Buy Landos to Strengthen Autoimmune Portfolio
Zacks via Yahoo Finance· 1 month agoAbbVie ABBV announced a definitive agreement to acquire Landos Biopharma LABP, which makes novel,...
10 Best Safe Dividend Stocks for Retirement Portfolios
Insider Monkey via Yahoo Finance· 1 year agoIn this article, we discuss the 10 best safe dividend stocks for retirement portfolios. If you want...
AbbVie Submits FDA Application For Continuous, 24-Hour Infusion Therapy For Parkinson's
Benzinga via Yahoo Finance· 2 years agoAbbVie Inc (NYSE: ABBV) submitted its FDA marketing application for ABBV-951, a solution of levodopa...
AbbVie's (ABBV) Skyrizi Meets Ulcerative Colitis Study Goals
Zacks via Yahoo Finance· 10 months agoAbbVie's (ABBV) Skyrizi achieves statistical significance with its primary endpoint of clinical...
AbbVie Walks Away From CytomX Partnership, But Garnering Attention Of Big Pharma Partners
Benzinga via Yahoo Finance· 1 year agoCytomX Therapeutics Inc (NASDAQ: CTMX) will weigh its options for CX-2029, a CD71-directed...
